Manulife (Manufacturers Life Insurance)
VTVT icon

Manulife (Manufacturers Life Insurance)’s vTv Therapeutics VTVT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-30
Closed -$2K – 3864
2018
Q2 		$2K Hold
30
– – ﹤0.01% 4217
2018
Q1 		$5K Sell
30
-37
-55% -$9.06K ﹤0.01% 4116
2017
Q4 		$16K Buy
67
+18
+37% +$4.04K ﹤0.01% 3863
2017
Q3 		$12K Buy
49
+13
+36% +$2.59K ﹤0.01% 3783
2017
Q2 		$7K Buy
36
+3
+9% +$625 ﹤0.01% 3868
2017
Q1 		$9K Hold
33
– – ﹤0.01% 3666
2016
Q4 		$6K Hold
33
– – ﹤0.01% 3900
2016
Q3 		$9K Hold
33
– – ﹤0.01% 3726
2016
Q2 		$8K Sell
33
-32
-49% -$7.36K ﹤0.01% 3693
2016
Q1 		$14K Buy
+65
New +$16.2K ﹤0.01% 3574

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s VTVT Position: Q3 2018 in Review

Manulife (Manufacturers Life Insurance) sold out of vTv Therapeutics (VTVT) in Q3 2018, closing a stake of 30 shares — an estimated $2K sold.

Manulife (Manufacturers Life Insurance) first reported a position in VTVT in Q1 2016 and held it in 10 quarters. The position peaked at $16K in Q4 2017. 19 funds tracked by Wall St. Rank hold VTVT as of Q3 2018.

  • Manulife (Manufacturers Life Insurance) reported no remaining vTv Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 30 vTv Therapeutics shares in Q3 2018, an estimated $2K.
  • Manulife (Manufacturers Life Insurance) first reported a position in vTv Therapeutics in Q1 2016 and held it in 10 quarters.
  • Manulife (Manufacturers Life Insurance)'s vTv Therapeutics position peaked at $16K in Q4 2017.
  • 19 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2018.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2018, filed 14 Nov 2018.